ATE286884T1 - Durch lymphe absorbierbare imidazolderivate - Google Patents
Durch lymphe absorbierbare imidazolderivateInfo
- Publication number
- ATE286884T1 ATE286884T1 AT97907316T AT97907316T ATE286884T1 AT E286884 T1 ATE286884 T1 AT E286884T1 AT 97907316 T AT97907316 T AT 97907316T AT 97907316 T AT97907316 T AT 97907316T AT E286884 T1 ATE286884 T1 AT E286884T1
- Authority
- AT
- Austria
- Prior art keywords
- lymph
- absorbable
- imidazole derivatives
- hydrate
- chem
- Prior art date
Links
- 210000002751 lymph Anatomy 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000001165 lymph node Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10329996 | 1996-03-28 | ||
| PCT/JP1997/000813 WO1997035843A1 (en) | 1996-03-28 | 1997-03-14 | Lymph-absorbable imidazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE286884T1 true ATE286884T1 (de) | 2005-01-15 |
Family
ID=14350384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97907316T ATE286884T1 (de) | 1996-03-28 | 1997-03-14 | Durch lymphe absorbierbare imidazolderivate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6054591A (de) |
| EP (1) | EP0893442B1 (de) |
| AT (1) | ATE286884T1 (de) |
| AU (1) | AU1940897A (de) |
| DE (1) | DE69732230T2 (de) |
| TW (1) | TW467904B (de) |
| WO (1) | WO1997035843A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1620091B1 (de) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Glutaminylcyclase-hemmer |
| ES2661009T3 (es) * | 2012-10-05 | 2018-03-27 | Neurovive Pharmaceutical Ab | Succinatos protegidos para mejorar la producción de ATP mitocondrial |
| CN117164657A (zh) * | 2014-08-12 | 2023-12-05 | 莫纳什大学 | 定向淋巴的前药 |
| CN118063537A (zh) | 2015-09-08 | 2024-05-24 | 莫纳什大学 | 定向淋巴的前药 |
| US11883497B2 (en) | 2017-08-29 | 2024-01-30 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
| EP4306524A3 (de) | 2017-08-29 | 2024-09-11 | PureTech LYT, Inc. | An das lymphatische system gerichtete lipidprodrugs |
| BR112020004729A2 (pt) * | 2017-09-20 | 2020-09-15 | Kao Corporation | composição em pó compreendendo corantes diretos para o cabelo |
| US11608345B1 (en) | 2017-12-19 | 2023-03-21 | Puretech Lyt, Inc. | Lipid prodrugs of rapamycin and its analogs and uses thereof |
| US11304954B2 (en) | 2017-12-19 | 2022-04-19 | Puretech Lyt, Inc. | Lipid prodrugs of mycophenolic acid and uses thereof |
| JP7810970B2 (ja) | 2020-02-05 | 2026-02-04 | シーポート・セラピューティクス・インコーポレイテッド | 神経ステロイドの脂質プロドラッグ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5216142A (en) * | 1989-04-17 | 1993-06-01 | Efamol Holdings Plc | Anti-virals |
| TW235963B (de) * | 1992-01-16 | 1994-12-11 | Shionogi & Co | |
| BR9509024A (pt) * | 1994-09-26 | 1997-09-30 | Shionogi & Co | Derivados de imidazol |
-
1997
- 1997-03-14 US US09/101,960 patent/US6054591A/en not_active Expired - Fee Related
- 1997-03-14 DE DE69732230T patent/DE69732230T2/de not_active Expired - Fee Related
- 1997-03-14 WO PCT/JP1997/000813 patent/WO1997035843A1/ja not_active Ceased
- 1997-03-14 EP EP97907316A patent/EP0893442B1/de not_active Expired - Lifetime
- 1997-03-14 AT AT97907316T patent/ATE286884T1/de not_active IP Right Cessation
- 1997-03-14 AU AU19408/97A patent/AU1940897A/en not_active Abandoned
- 1997-03-26 TW TW086103842A patent/TW467904B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0893442A1 (de) | 1999-01-27 |
| EP0893442A4 (de) | 2002-07-17 |
| TW467904B (en) | 2001-12-11 |
| US6054591A (en) | 2000-04-25 |
| DE69732230D1 (de) | 2005-02-17 |
| WO1997035843A1 (en) | 1997-10-02 |
| AU1940897A (en) | 1997-10-17 |
| DE69732230T2 (de) | 2005-12-22 |
| EP0893442B1 (de) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE168373T1 (de) | Benzofuranyl- und thiophenylalkancarbonsäurederivate | |
| DE3677452D1 (de) | Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE58902284D1 (de) | Tetrahydro-1-benz-(c,d)-indol-propionsaeure-sulfonamide. | |
| WO2000047580A3 (en) | Phenyl urea and phenyl thiourea derivatives | |
| DE69732230D1 (de) | Durch lymphe absorbierbare imidazolderivate | |
| FI842798A0 (fi) | Mot denaturering skyddade vattenloesningar av proteiner, foerfarande foer deras framstaellning och deras anvaendning. | |
| DK1447400T3 (da) | Bicyklisk forbindelse | |
| ATE266663T1 (de) | Acrylamid-derivate und verfahren zu deren herstellung | |
| ES2052937T3 (es) | Derivados de imidazol sustituido y su procedimiento de preparacion y su utilizacion. | |
| EA199900754A1 (ru) | Способ получения замещенного тиазолидиндиона | |
| BRPI0411664A (pt) | composição oral antiplaca aquosa estável | |
| DE69909165D1 (de) | Verfahren zur Herstellung von N-Glycyltyrosin | |
| DE69915514D1 (de) | Prenyltransferase-inhibitoren | |
| CA2161219A1 (en) | Process to prepare p-alkyl- and p-arylsulphonylbenzoic acid derivatives | |
| EP1283210A4 (de) | Verfahren zur herstellung von sulfonamidderivaten und ihrer kristalle | |
| NO305753B1 (no) | Ny 4-imidazolidinonforbindelse, fremgangsmÕte ved dens fremstilling og farmas°ytiske sammensetninger inneholdende den | |
| ES2040223T3 (es) | Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion. | |
| DE69612237D1 (de) | Verfahren zur Herstellung von alpha-Methyl-2-thiophenessigsäure-Derivaten | |
| JPS5587769A (en) | Preparation of pyrroleacetic acid derivative | |
| EA200100163A1 (ru) | Новые производные 6-деоксиэритромицина, способ их получения и их применение в качестве лекарственных средств | |
| RU99110015A (ru) | Способ подготовки плодов или овощей к хранению | |
| JPS56142286A (en) | Preparation of penicillin 1-oxide | |
| ES8303319A1 (es) | "un procedimiento para obtener derivados de biciclooctano". | |
| RU99110245A (ru) | Способ хранения плодов или овощей | |
| FI863897L (fi) | Kemiskt foerfarande. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |